Paola Cappello

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma.

The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 15, 2026

The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma.

The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma.

Journal: Clinical and translational medicine

Published: April 08, 2025

Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration.

Loss of aryl hydrocarbon receptor reduces pancreatic tumor growth by increasing immune cell infiltration.

Journal: Biochemical pharmacology

Published: December 04, 2024

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.

Loss of Parp7 increases type I interferon signalling and reduces pancreatic tumour growth by enhancing immune cell infiltration.

Journal: Frontiers in immunology

Published: October 18, 2024

mTOR Inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence.

mTOR Inhibition limits LPS induced acute kidney injury and ameliorates hallmarks of cellular senescence.

Journal: Scientific reports

Published: September 06, 2024

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.

In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens.

Journal: Frontiers in immunology

Published: May 03, 2024

PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.

PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 21, 2024

Exploiting pancreatic cancer metabolism: challenges and opportunities.

Exploiting pancreatic cancer metabolism: challenges and opportunities.

Journal: Trends in molecular medicine

Published: January 15, 2024

Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer.

Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer.

Journal: International journal of molecular sciences

Published: December 28, 2023

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance.

Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance.

Journal: Frontiers in oncology

Published: September 06, 2023

A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia.

A neuroligin-2-YAP axis regulates progression of pancreatic intraepithelial neoplasia.

Journal: EMBO reports

Published: June 05, 2023

IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer.

IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer.

Journal: Nature

Published: December 12, 2022

Showing 1-12 of 70

Last Updated: 09/26/2026